Medicinal Plant Pharmacodynamics Research
Medicinal Plant Pharmacodynamics Research is a research topic within Pharmacology. Science Explorer counts 13k research works in it since 1950. 7.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the ethnopharmacological, phytochemical, and pharmacological properties of the Epimedium genus, focusing on the bioactive compound icariin and its derivatives. The research covers a wide range of topics including anti-cancer properties, neuroprotective effects, estrogenic activity, metabolism, apoptosis induction, and angiogenesis stimulation.
- Icariin
- Pharmacological Effects
- Flavonoids
- Osteoblastic Differentiation
- Anti-Cancer Properties
- Neuroprotective Effects
- Estrogenic Activity
- Metabolism
- Apoptosis Induction
- Angiogenesis Stimulation
- Research works
- 13k fractional, since 1950
- In the world top 10%
- 945 per year above
- Top-10% rate
- 7.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -52% the tick is no change
Which countries lead Medicinal Plant Pharmacodynamics Research research?
By volume, China and the United States publish the most (679 and 36 works in 2022–2025).
By volume, 2022–2025
- 1 China 679 works
- 2 United States 36 works
- 3 India 24 works
- 4 Indonesia 18 works
- 5 South Korea 18 works
- 6 Iran 15 works
- 7 Russia 10 works
- 8 Egypt 10 works
- 9 Türkiye 10 works
- 10 Japan 9 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Medicinal Plant Pharmacodynamics Research research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Medicinal Plant Pharmacodynamics Research research, followed by Nanjing University of Chinese Medicine and Beijing University of Chinese Medicine.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical College China 22 works
- 2 Nanjing University of Chinese Medicine China 17 works
- 3 Beijing University of Chinese Medicine China 12 works
- 4 Shanghai University of Traditional Chinese Medicine China 11 works
- 5 Shandong University of Traditional Chinese Medicine China 10 works
- 6 Zhejiang Chinese Medical University China 10 works
- 7 Zunyi Medical University China 9 works
- 8 Jiangxi University of Traditional Chinese Medicine China 8 works
- 9 China Academy of Chinese Medical Sciences China 8 works
- 10 Chengdu University of Traditional Chinese Medicine China 8 works
Where is Medicinal Plant Pharmacodynamics Research research done?
The largest centres of Medicinal Plant Pharmacodynamics Research research in 2022–2025 are Beijing (China), Shanghai (China), Nanjing (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Jinan.
Largest cities, 2022–2025
Where it is the local speciality
- JinanCN · 22.9 works6.5×
Location quotient: how much more of its research is in Medicinal Plant Pharmacodynamics Research than the world average.
Where is the best place to study Medicinal Plant Pharmacodynamics Research?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Zunyi Medical University and Shandong University of Traditional Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 42.8 | 22.9% | 25.4× | 22 | -57.7% |
| 2 | Zunyi Medical University China | 38.2 | 32.6% | 66.2× | 9 | -7.8% |
| 3 | Shandong University of Traditional Chinese Medicine China | 34.1 | 44.1% | 91.0× | 10 | -88.7% |
| 4 | Nanjing University of Chinese Medicine China | 22.9 | 14.4% | 79.5× | 17 | -73.5% |
| 5 | Zhejiang Chinese Medical University China | 22.9 | 30.5% | 43.2× | 10 | -81.3% |
| 6 | Shanghai University of Traditional Chinese Medicine China | 20.1 | 21.9% | 63.4× | 11 | -80.7% |
| 7 | Beijing University of Chinese Medicine China | 17.1 | 15.9% | 78.7× | 12 | -65.7% |
| 8 | Jiangxi University of Traditional Chinese Medicine China | 0.6 | 7.2% | 126.5× | 8 | -73.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Medicinal Plant Pharmacodynamics Research research growing?
Output in 2018–2022 was 52% lower than in 2013–2017, peaking in 2011.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.